[go: up one dir, main page]

WO1991011117A3 - Complements alimentaires comprenant des vitamines et des sels mineraux - Google Patents

Complements alimentaires comprenant des vitamines et des sels mineraux Download PDF

Info

Publication number
WO1991011117A3
WO1991011117A3 PCT/US1991/000719 US9100719W WO9111117A3 WO 1991011117 A3 WO1991011117 A3 WO 1991011117A3 US 9100719 W US9100719 W US 9100719W WO 9111117 A3 WO9111117 A3 WO 9111117A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
minerals
formulations
vitamins
formulation
Prior art date
Application number
PCT/US1991/000719
Other languages
English (en)
Other versions
WO1991011117A2 (fr
Inventor
Thomas J Slaga
Daryl L Deluca
William S Sparks
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Priority to JP91504510A priority Critical patent/JPH05505935A/ja
Priority to DE69124223T priority patent/DE69124223T2/de
Priority to BR919105986A priority patent/BR9105986A/pt
Priority to EP91904156A priority patent/EP0514451B1/fr
Priority to CA002074527A priority patent/CA2074527A1/fr
Publication of WO1991011117A2 publication Critical patent/WO1991011117A2/fr
Publication of WO1991011117A3 publication Critical patent/WO1991011117A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Formulation de vitamines, minéraux et autres compléments avantageux. On croit que les formulations de l'invention non seulement prolongent la longévité mais également protègent contre les maladies telles que certains cancers et troubles cardiovasculaires, et facilitent l'intégrité immunologique chez l'homme. Plus spécifiquement, l'invention concerne une formulation ainsi que des procédés de fabrication et d'administration d'une formulation contenant des vitamines ainsi que des minéraux associés à des antioxydants, des huiles de poisson, des enzymes, ainsi que des acides aminés. Les formulations de l'invention permettent des relations synergiques n'ayant pas été constatées antérieurement. Selon le mode de réalisation préféré, les formulations de l'invention sont fabriquées sous forme de complément alimentaire en comprimés, à libération entretenue, et ils constituent des compléments quotidiens.
PCT/US1991/000719 1990-02-05 1991-02-04 Complements alimentaires comprenant des vitamines et des sels mineraux WO1991011117A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP91504510A JPH05505935A (ja) 1990-02-05 1991-02-04 ビタミン，ミネラルおよび他の有利な補給剤の徐放性処方
DE69124223T DE69124223T2 (de) 1990-02-05 1991-02-04 Vitamine und mineralien enthaltende nahrungszusätze
BR919105986A BR9105986A (pt) 1990-02-05 1991-02-04 Formulacao de liberacao por tempo de vitaminas,minerais e outros suplementos beneficos
EP91904156A EP0514451B1 (fr) 1990-02-05 1991-02-04 Complements alimentaires comprenant des vitamines et des sels mineraux
CA002074527A CA2074527A1 (fr) 1990-02-05 1991-02-04 Supplements alimentaires a base de vitamines et de mineraux

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47564190A 1990-02-05 1990-02-05
US475,641 1990-02-05

Publications (2)

Publication Number Publication Date
WO1991011117A2 WO1991011117A2 (fr) 1991-08-08
WO1991011117A3 true WO1991011117A3 (fr) 1991-09-19

Family

ID=23888480

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/000719 WO1991011117A2 (fr) 1990-02-05 1991-02-04 Complements alimentaires comprenant des vitamines et des sels mineraux

Country Status (7)

Country Link
EP (1) EP0514451B1 (fr)
JP (1) JPH05505935A (fr)
AT (1) ATE147592T1 (fr)
AU (1) AU646840B2 (fr)
BR (1) BR9105986A (fr)
DE (1) DE69124223T2 (fr)
WO (1) WO1991011117A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005637B2 (en) 2007-06-26 2015-04-14 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
US9597404B2 (en) 2007-03-13 2017-03-21 Jds Therapeutics, Llc Methods and compositions for sustained release of chromium
CN107257676A (zh) * 2014-12-30 2017-10-17 西蒙尼·海克 生发剂或膳食补充剂

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
FR2691616B1 (fr) * 1992-05-27 1995-06-09 Thorel Jean Noel Bio-vecteurs nutritionnels.
BE1006217A6 (fr) * 1992-09-10 1994-06-14 Steils Anne Epouse Gerome Boisson lactee enrichie de nutriments.
CA2105881A1 (fr) * 1992-09-14 1994-03-15 Willem Jacob Serfontein Compositions pour le traitement et la prophylaxie des troubles metaboliques chez le nourrisson
CN1087517A (zh) * 1992-09-14 1994-06-08 韦斯塔药品有限公司 用于降低高半胱氨酸水平的药物制剂
US5354902A (en) * 1992-10-26 1994-10-11 Mcneil-Ppc, Inc. Stabilized sorbic acid or salt thereof
FR2704394B1 (fr) * 1993-04-27 1995-06-02 Boiron Complément nutritionnel absorbable pour le traitement des cheveux et des ongles.
FR2704391B1 (fr) * 1993-04-27 1995-06-02 Boiron Complément nutritionnel absorbable pour faciliter l'adaptation au stress quodidien.
FR2704397B1 (fr) * 1993-04-30 1995-06-02 Boiron Complément nutritionnel absorbable destiné à optimiser la résistance de l'organisme aux effets de la pollution urbaine.
GB2284153B (en) * 1993-05-21 1998-02-25 Radopath Ltd Substances for use in treatment of HIV-infection in HIV-infected patients
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
CN1080855A (zh) * 1993-05-22 1994-01-19 黎均耀 维生素矿物质防癌复方
US5451414A (en) * 1994-03-15 1995-09-19 Heritage Environmental Services, Inc. Micronutrient supplement
FR2723682B1 (fr) * 1994-08-19 1996-09-27 Boiron Complement nutritionnel absorbable pour l'equilibre quotidien de l'enfant et l'adolescent.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2737849B1 (fr) * 1995-08-18 1997-09-19 Boiron Complement nutritionnel absorbable pour l'equilibre quotidien des seniors
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
IT1283478B1 (it) * 1996-07-22 1998-04-21 Roberto Valducci Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
AU6765798A (en) * 1997-03-20 1998-10-12 Coventry Group, Ltd. Nutritional supplement for cardiovascular health
DE59712694D1 (de) * 1997-04-18 2006-08-24 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate
GB9713620D0 (en) * 1997-06-28 1997-09-03 Boots Co Plc Composition
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
DE69831576T2 (de) * 1997-08-08 2006-06-14 Nutrition 21 Llc Chromium/biotin behandlung von typ-ii diabetes
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
AU777968B2 (en) * 1998-06-10 2004-11-04 Albert B. Crum Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
DE19831798A1 (de) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Mittel zur Pflege und/oder Behandlung von Haut und Gewebe
WO2000007463A1 (fr) * 1998-08-04 2000-02-17 Kv Pharmaceutical Company Complements de multivitamines et mineraux, destines aux femmes
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
IL141967A0 (en) 1998-09-17 2002-03-10 Akesis Pharm Inc Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
PT1128835E (pt) * 1998-12-28 2006-11-30 Cobalis Corp Tratamento com cianocobalamina (vitamina b12) em doença alérgica
US6139881A (en) * 1999-02-09 2000-10-31 Thompson Animal Systems, Inc. Chromium-carboxylic acid feed supplement
CZ9900555A3 (cs) * 1999-02-19 2000-10-11 Radomír Ing. Špetík Způsob mimotělní identifikace maligního a jiného onemocnění lidí a směs látek jako stimulantu krve
AU768189B2 (en) * 1999-06-15 2003-12-04 Nutri-Logics, Inc. Nutrient formulations for disease reduction, and related treatment and component screening methods
RU2268069C2 (ru) 2000-04-18 2006-01-20 Сосьете Де Продюи Нестле С.А. Питательные модули
DK1155620T3 (da) * 2000-05-18 2005-12-05 Mega Healthcare As Q Kosttilskudsmiddel med vitaminer, mineraler og flerumættede fedtsyrer
CN1114618C (zh) * 2000-05-19 2003-07-16 程伶辉 三价铬复合物、其乳制品及其制造方法
GB0016452D0 (en) * 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
US20020155170A1 (en) 2000-11-30 2002-10-24 Walsh William John Nutrient supplements and methods for treating autism and for preventing the onset of autism
DE60232140D1 (de) * 2001-03-23 2009-06-10 Nutricia Nv Zusammensetzung zur prävention und/oder behandlung von verändertem knochenmetabolismus
US20040137036A1 (en) * 2001-05-09 2004-07-15 Yoshitane Kojima Zinc-containing foods
DE10137827A1 (de) * 2001-08-02 2003-02-27 Peter Marcinowski Komplexes Antioxidantienpräparat
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
AT502590A1 (de) * 2001-09-27 2007-04-15 Oekopharm Forschungs Und Entwi Basenhältige mikronährstoffmischung
FR2831396B1 (fr) * 2001-10-31 2004-04-02 Moulin Du Chatel Aliment pour poules pondeuses destine a la production d'oeufs comestibles enrichis en iode et en acides gras polyinsatures et procede d'alimentation de poules pondeuses correspondant
EP2260845A3 (fr) * 2002-06-21 2012-08-22 L'Oréal Utilisation de polyphénol pour le traitement de l'alopécie
FR2841128B1 (fr) * 2002-06-21 2004-12-03 Oreal Utilisation pour le traitement oral de l'alopecie de taurine ou d'hypotaurine et compositions en comportant
AU2002343768A1 (en) * 2002-10-28 2004-05-13 Motomura, Michiyo Metal compositions capable of removing active oxygen
JP4712300B2 (ja) * 2002-12-26 2011-06-29 クラシエ製薬株式会社 美白剤及びビタミン混合組成物
EP1587377A2 (fr) * 2003-01-31 2005-10-26 The Procter & Gamble Company Moyen pour ameliorer l'aspect de tissus keratiniques de mammiferes
JP4569802B2 (ja) * 2003-07-23 2010-10-27 眞 八藤 ビタミンを主材とするイオン化ミネラル結合型サプリメントの製造方法
JP2005104852A (ja) * 2003-09-29 2005-04-21 Kyowa Hakko Kogyo Co Ltd モービリウィルス感染症の予防または治療用組成物
FR2860976B1 (fr) * 2003-10-20 2006-02-10 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.
FR2863497B1 (fr) * 2003-12-10 2006-04-21 Synergia Holding Nouvelles compositions pharmaceutiques et/ou dietetiques contre le stress
ITMI20041772A1 (it) * 2004-09-17 2004-12-17 Bioprogress Spa Formulazione a rilascio controllato di tiamina e loro impiego nel trattamento di patologie collegate a difetti nei processi di apprendimento e memorizzazione.
EP2368442B1 (fr) 2005-07-27 2014-12-17 Symrise AG Utilisation d'hespérétine pour améliorer le goût sucré
EP2305222A1 (fr) * 2006-04-04 2011-04-06 Hill's Pet Nutrition, Inc. Compositions et procedes visant a accroitre le statut antioxydant des animals
EP1952796A1 (fr) * 2006-09-08 2008-08-06 DSMIP Assets B.V. Compositions pour le soin de la peau
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
JP5537151B2 (ja) 2007-04-05 2014-07-02 株式会社Ｊ−オイルミルズ 精神安定剤および機能性食品
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
CA2695366C (fr) 2007-08-03 2016-10-04 Shaklee Corporation Systeme de complement nutritionnel
US8911798B2 (en) * 2007-09-17 2014-12-16 Ajay Gupta Multivitamin and mineral compositions for individuals having renal disease
WO2009087647A1 (fr) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research Formulation stabilisée de concentré d'iode et d'eau, utile pour une protection contre des troubles liés à une carence en iode
US9986752B2 (en) * 2008-05-23 2018-06-05 Lawrence M. Green Base medicinal liquid formulation for supporting the specific homeostatic acid-base balance of living tissue
US8324191B2 (en) * 2008-07-11 2012-12-04 Biolink Life Sciences, Inc Combined calcium, magnesium and vitamin D supplements
EP2210593A3 (fr) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Formulations de vitamine A et dérivés correspondants pouvant être mis en comprimés
WO2012038985A2 (fr) * 2010-09-23 2012-03-29 Tata Global Beverages Limited Composition d'enrichissement en chrome trivalent et en bore, complément d'hydratation et procédé de préparation de ceux-ci
WO2012119007A1 (fr) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions d'insuline et de chrome pour traitement et prévention du diabète, de l'hypoglycémie et de troubles associés
JP2013177356A (ja) * 2012-02-29 2013-09-09 Shiseido Co Ltd 紫外線曝露によって促進される血管新生を抑制するための組成物
WO2014192792A1 (fr) * 2013-05-30 2014-12-04 大正製薬株式会社 Préparation liquide pour l'utilisation interne
WO2015153552A1 (fr) * 2014-03-31 2015-10-08 Yale University Inhibiteur de sécrétion d'acide gastrique à action radipe et à activité accrue
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
US12016849B2 (en) * 2016-10-12 2024-06-25 Bonafide Health, Llc Magnesium picolinate compositions and methods of use
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
JP2022509354A (ja) * 2018-10-23 2022-01-20 ホーグ、ジョージ、エドワード 肺を処置するための組成物および方法
FR3087650B1 (fr) * 2018-10-31 2021-01-29 Bio Even Flavine adenine dinucleotide (fad) pour son utilisation pour la prevention et/ou le traitement de cancer
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
AR118962A1 (es) * 2019-05-22 2021-11-10 Bayer Consumer Care Ag Preparaciones de cápsulas de gelatina blanda de vitaminas y minerales que comprenden vitamina c en forma de una sal de ascorbato
WO2021205083A2 (fr) * 2020-04-11 2021-10-14 Finindsutria Srl Composition pour la prévention ou le traitement du covid-19
WO2023016471A1 (fr) * 2021-08-10 2023-02-16 武汉远大弘元股份有限公司 Composition, formulation, procédé de préparation et utilisation pour un précurseur de glutathion
TW202519203A (zh) * 2023-08-01 2025-05-16 日商Ｓｓ製藥股份有限公司 組合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
EP0129032A2 (fr) * 1983-06-13 1984-12-27 Suntory Limited Une préparation inoffensive à base de vitamine C
FR2569536A1 (fr) * 1984-08-30 1986-03-07 Michel Maillols Nutriments biologiques
EP0259167A2 (fr) * 1986-09-05 1988-03-09 Phillip Lowell Millman Composition nutritive pour athlètes et méthode pour sa production et son utilisation
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60102169A (ja) * 1983-11-08 1985-06-06 Sumitomo Chem Co Ltd カロチノイド類含有組成物およびその製法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
EP0129032A2 (fr) * 1983-06-13 1984-12-27 Suntory Limited Une préparation inoffensive à base de vitamine C
FR2569536A1 (fr) * 1984-08-30 1986-03-07 Michel Maillols Nutriments biologiques
EP0259167A2 (fr) * 1986-09-05 1988-03-09 Phillip Lowell Millman Composition nutritive pour athlètes et méthode pour sa production et son utilisation
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597404B2 (en) 2007-03-13 2017-03-21 Jds Therapeutics, Llc Methods and compositions for sustained release of chromium
US9005637B2 (en) 2007-06-26 2015-04-14 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
US9421170B2 (en) 2007-06-26 2016-08-23 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
US11850308B2 (en) 2007-06-26 2023-12-26 Bonafide Health, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
CN107257676A (zh) * 2014-12-30 2017-10-17 西蒙尼·海克 生发剂或膳食补充剂

Also Published As

Publication number Publication date
ATE147592T1 (de) 1997-02-15
DE69124223D1 (de) 1997-02-27
BR9105986A (pt) 1992-11-10
JPH05505935A (ja) 1993-09-02
WO1991011117A2 (fr) 1991-08-08
EP0514451B1 (fr) 1997-01-15
AU7241491A (en) 1991-08-21
EP0514451A1 (fr) 1992-11-25
DE69124223T2 (de) 1997-04-30
AU646840B2 (en) 1994-03-10

Similar Documents

Publication Publication Date Title
WO1991011117A3 (fr) Complements alimentaires comprenant des vitamines et des sels mineraux
IL128153A0 (en) Nutritional formula for phenylketonuria patients
CA2262972A1 (fr) Compositions a base d'hydrates de carbone de plantes comme supplements dietetiques
Furukawa et al. Reversal of age-associated decline in immune responsiveness by dietary glutathione supplementation in mice
CA2229279A1 (fr) Compose nutritionnel et/ou dietetique et son procede d'utilisation
WO1999047135A8 (fr) Compositions a base d'acides linoleiques conjugues
CA2242114A1 (fr) Supplement nutritionnel pour le traitement et la prevention de la permeabilite intestinale excessive
CA2372614A1 (fr) Procede et produit permettant de renforcer la reponse immunitaire chez les animaux de compagnie au moyen d'une combinaison d'antioxydants
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
CA2159058A1 (fr) Inhibition de l'helicobacter
CA2086247A1 (fr) Compositions alimentaires et pharmaceutiques contenant des acides gras monoinsatures a courte chaine et leurs modes d'emploi
CA2355341A1 (fr) L'utilisation d'ara comme supplement pour une femme qui allaite
EP0189160A3 (fr) Composition entérale nutritive à haute teneur en graisse et basse teneur en hydrates de carbone
WO2001019356A3 (fr) Regime riche en lipide
AU4046693A (en) Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
EA200000377A1 (ru) Композиция для подавления симптомов абстиненции и тяги к алкоголю у алкоголиков и профилактики злоупотребления алкоголем у здоровых людей
CA2122431A1 (fr) Administration topique de vitamine d aux mammiferes et compositions
EP0669835A1 (fr) Compositions dietetiques hypocholesterolemiques comprenant des proteines de soja et des sitosterols
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
EP0388237A3 (fr) Produit diététique
GB9712420D0 (en) Food
GR3030650T3 (en) Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements
CA2374471A1 (fr) Derives de principes actifs ameliores d'un point de vue therapeutique et/ou nutritionnel, et compositions administrees par voie orale contenant ces derives
Wilson et al. The influence of an extract of orange peel on the growth and ascorbic acid metabolism of young guinea‐pigs
WO1999037167A3 (fr) Procede pour ameliorer la stabilite de la vitamine d dans un produit nutritionnel contenant une proteine hydrolysee, et produit obtenu par ce procede

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MC MG MW NL NO RO SD SE SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2074527

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991904156

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1991904156

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991904156

Country of ref document: EP